coronavius

Novavax, Inc (NASDAQ: NVAX) announced Friday it has reached terms with the government of the United Kingdom to supply 60 million doses of its COVID-19 vaccine, subject to success of pending clinical trials. What Happened The Maryland-based company will supply the U.K. with its NVX-CoV2373...

In February, when the first coronavirus-infected cruise goers came home to the U.S., the biodefense lab in Galveston pulled from its freezer one of five antiviral drug candidates developed by Celgene spinoff Trek Therapeutics. Its test on COVID-19 patients yielded a 98.6% response rate. It was...